Diagnostic Performance and Safety of <sup>18</sup> F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT)-Reference-Cited by-同舟云学术

Diagnostic Performance and Safety of ¹⁸ F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT)

Published:2023-08 Issue:2 Volume:210 Page:299-311
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Jani Ashesh B.¹,Ravizzini Gregory C.²,Gartrell Benjamin A.³,Siegel Barry A.⁴,Twardowski Przemyslaw⁵,Saltzstein Daniel⁶,Fleming Mark T.⁷,Chau Albert⁸,Davis Phillip⁹,Chapin Brian F.¹⁰,Schuster David M.¹¹,Allaf Mohamad,Avery Ryan J.,Avril Norbert,Barker Helen,Belkoff Laurence,Bostrom Peter,Cher Michael L.,Chisholm Diane,Covington Matthew F.,Cox Ian,Esposito Giuseppe,Gardiner Peter,Gauden David,Helfand Brian,Hermsen Rick,Josephson David,Kay Matthew,Koontz Bridget F.,Kostakoglu Lale,Kuo Phillip,Lavely William,Liem Ing Han,Lokuta Mary,Lowentritt Benjamin,Michalski Jeff,Miller Matthew P.,Mourtzikos Karen,Pachynski Russell,Penny Ross,Piert Morand,Purysko Andrei,Rais-Bahrami Soroush,Savir-Baruch Bital,Somford Rik,Tewari Ashutosh,Uchio Edward,Yoo Don,Zukotynski Katherine

Affiliation:

1. Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia

2. Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas

3. Department of Medical Oncology, Montefiore Medical Center, Bronx, New York

4. Division of Nuclear Medicine, Mallinckrodt Institute of Radiology and the Alvin J. Siteman Cancer Center, Washington University School of Medicine, St Louis, Missouri

5. Department of Genitourinary Oncology, John Wayne Cancer Institute, Santa Monica, California

6. Urology San Antonio, San Antonio, Texas

7. Virginia Oncology Associates, US Oncology Research, Norfolk, Virginia

8. Blue Earth Diagnostics Ltd, Oxford, United Kingdom

9. Blue Earth Diagnostics Inc, Monroe Township, New Jersey

10. Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas

11. Division of Nuclear Medicine and Molecular Imaging, Department of Radiology and Imaging Sciences, Emory University, Atlanta, Georgia

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Link

http://www.auajournals.org/doi/pdf/10.1097/JU.0000000000003493

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 18F-Flotufolastat Positron Emission Tomography in African American Patients With Suspected Prostate Cancer Recurrence: Findings From the Phase 3 SPOTLIGHT Study;Advances in Radiation Oncology;2024-09

2. From Oncogenesis to Theranostics: The Transformative Role of PSMA in Prostate Cancer;Cancers;2024-08-31

3. Impact of Clinical Factors on 18F-Flotufolastat Detection Rates in Men With Recurrent Prostate Cancer: Exploratory Analysis of the Phase 3 SPOTLIGHT Study;Advances in Radiation Oncology;2024-08

4. Comparison of 18F-DCFPyL and 68Ga-PSMA-11 for 177Lu-PSMA-617 therapy patient selection;Frontiers in Oncology;2024-06-27

5. Emerging and anticipated innovations in prostate cancer MRI and their impact on patient care;Abdominal Radiology;2024-06-14